Diagnosis and treatment of chronic immune-mediated neuropathies

Norman Latov; Kenneth C. Gorson; Thomas H. Brannagan; Roy L. Freeman; Slobodan Apostolski; Alan R. Berger; Walter G. Bradley; Chiara Briani; Vera Bril; Neil A. Busis; Didier P. Cros; Marinos C. Dalakas; Peter D. Donofrio; P. James B. Dyck; John D. England; Morris A. Fisher; David N. Herrmann; Daniel L. Menkes; Zarife Sahenk; Howard W. Sander; William J. Triggs; Jean Michel Vallat

doi:10.1097/01.cnd.0000205575.26451.e4

Diagnosis and treatment of chronic immune-mediated neuropathies

Norman Latov, Kenneth C. Gorson, Thomas H. Brannagan, Roy L. Freeman, Slobodan Apostolski, Alan R. Berger, Walter G. Bradley, Chiara Briani, Vera Bril, Neil A. Busis, Didier P. Cros, Marinos C. Dalakas, Peter D. Donofrio, P. James B. Dyck, John D. England, Morris A. Fisher, David N. Herrmann, Daniel L. Menkes, Zarife Sahenk, Howard W. SanderWilliam J. Triggs, Jean Michel Vallat

Neurology

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

The chronic autoimmune neuropathies are a diverse group of disorders, whose diagnosis and classification is based on the clinical presentations and results of ancillary tests. In chronic inflammatory demyelinating polyneuropathy, controlled therapeutic trials demonstrated efficacy for intravenous γ-globulins, corticosteroids, and plasmaphereis. In multifocal motor neuropathy, intravenous γ-globulins have been shown to be effective. In the other immune-mediated neuropathies, there are no reported controlled therapeutic trials, but efficacy has been reported for some treatments in non-controlled trials on case studies. Choice of therapy in individual cases is based on reported efficacy, as well as severity, progression, coexisting illness, predisposition to developing complications, and potential drug interactions.

Original language	English (US)
Pages (from-to)	141-157
Number of pages	17
Journal	Journal of clinical neuromuscular disease
Volume	7
Issue number	3
DOIs	https://doi.org/10.1097/01.cnd.0000205575.26451.e4
State	Published - Mar 2006

Keywords

Autoimmune neuropathy
Diagnosis
Inflammatory neuropathy
Peripheral neuropathy
Therapy
Vasculitic neuropathy

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1097/01.cnd.0000205575.26451.e4

Cite this

Latov, N., Gorson, K. C., Brannagan, T. H., Freeman, R. L., Apostolski, S., Berger, A. R., Bradley, W. G., Briani, C., Bril, V., Busis, N. A., Cros, D. P., Dalakas, M. C., Donofrio, P. D., Dyck, P. J. B., England, J. D., Fisher, M. A., Herrmann, D. N., Menkes, D. L., Sahenk, Z., ... Vallat, J. M. (2006). Diagnosis and treatment of chronic immune-mediated neuropathies. Journal of clinical neuromuscular disease, 7(3), 141-157. https://doi.org/10.1097/01.cnd.0000205575.26451.e4

Latov, N, Gorson, KC, Brannagan, TH, Freeman, RL, Apostolski, S, Berger, AR, Bradley, WG, Briani, C, Bril, V, Busis, NA, Cros, DP, Dalakas, MC, Donofrio, PD, Dyck, PJB, England, JD, Fisher, MA, Herrmann, DN, Menkes, DL, Sahenk, Z, Sander, HW, Triggs, WJ & Vallat, JM 2006, 'Diagnosis and treatment of chronic immune-mediated neuropathies', Journal of clinical neuromuscular disease, vol. 7, no. 3, pp. 141-157. https://doi.org/10.1097/01.cnd.0000205575.26451.e4

@article{7f4562ff07ee4c4b97f9193db454adda,

title = "Diagnosis and treatment of chronic immune-mediated neuropathies",

abstract = "The chronic autoimmune neuropathies are a diverse group of disorders, whose diagnosis and classification is based on the clinical presentations and results of ancillary tests. In chronic inflammatory demyelinating polyneuropathy, controlled therapeutic trials demonstrated efficacy for intravenous γ-globulins, corticosteroids, and plasmaphereis. In multifocal motor neuropathy, intravenous γ-globulins have been shown to be effective. In the other immune-mediated neuropathies, there are no reported controlled therapeutic trials, but efficacy has been reported for some treatments in non-controlled trials on case studies. Choice of therapy in individual cases is based on reported efficacy, as well as severity, progression, coexisting illness, predisposition to developing complications, and potential drug interactions.",

keywords = "Autoimmune neuropathy, Diagnosis, Inflammatory neuropathy, Peripheral neuropathy, Therapy, Vasculitic neuropathy",

author = "Norman Latov and Gorson, {Kenneth C.} and Brannagan, {Thomas H.} and Freeman, {Roy L.} and Slobodan Apostolski and Berger, {Alan R.} and Bradley, {Walter G.} and Chiara Briani and Vera Bril and Busis, {Neil A.} and Cros, {Didier P.} and Dalakas, {Marinos C.} and Donofrio, {Peter D.} and Dyck, {P. James B.} and England, {John D.} and Fisher, {Morris A.} and Herrmann, {David N.} and Menkes, {Daniel L.} and Zarife Sahenk and Sander, {Howard W.} and Triggs, {William J.} and Vallat, {Jean Michel}",

year = "2006",

month = mar,

doi = "10.1097/01.cnd.0000205575.26451.e4",

language = "English (US)",

volume = "7",

pages = "141--157",

journal = "Journal of clinical neuromuscular disease",

issn = "1522-0443",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Diagnosis and treatment of chronic immune-mediated neuropathies

AU - Latov, Norman

AU - Gorson, Kenneth C.

AU - Brannagan, Thomas H.

AU - Freeman, Roy L.

AU - Apostolski, Slobodan

AU - Berger, Alan R.

AU - Bradley, Walter G.

AU - Briani, Chiara

AU - Bril, Vera

AU - Busis, Neil A.

AU - Cros, Didier P.

AU - Dalakas, Marinos C.

AU - Donofrio, Peter D.

AU - Dyck, P. James B.

AU - England, John D.

AU - Fisher, Morris A.

AU - Herrmann, David N.

AU - Menkes, Daniel L.

AU - Sahenk, Zarife

AU - Sander, Howard W.

AU - Triggs, William J.

AU - Vallat, Jean Michel

PY - 2006/3

Y1 - 2006/3

N2 - The chronic autoimmune neuropathies are a diverse group of disorders, whose diagnosis and classification is based on the clinical presentations and results of ancillary tests. In chronic inflammatory demyelinating polyneuropathy, controlled therapeutic trials demonstrated efficacy for intravenous γ-globulins, corticosteroids, and plasmaphereis. In multifocal motor neuropathy, intravenous γ-globulins have been shown to be effective. In the other immune-mediated neuropathies, there are no reported controlled therapeutic trials, but efficacy has been reported for some treatments in non-controlled trials on case studies. Choice of therapy in individual cases is based on reported efficacy, as well as severity, progression, coexisting illness, predisposition to developing complications, and potential drug interactions.

AB - The chronic autoimmune neuropathies are a diverse group of disorders, whose diagnosis and classification is based on the clinical presentations and results of ancillary tests. In chronic inflammatory demyelinating polyneuropathy, controlled therapeutic trials demonstrated efficacy for intravenous γ-globulins, corticosteroids, and plasmaphereis. In multifocal motor neuropathy, intravenous γ-globulins have been shown to be effective. In the other immune-mediated neuropathies, there are no reported controlled therapeutic trials, but efficacy has been reported for some treatments in non-controlled trials on case studies. Choice of therapy in individual cases is based on reported efficacy, as well as severity, progression, coexisting illness, predisposition to developing complications, and potential drug interactions.

KW - Autoimmune neuropathy

KW - Diagnosis

KW - Inflammatory neuropathy

KW - Peripheral neuropathy

KW - Therapy

KW - Vasculitic neuropathy

UR - http://www.scopus.com/inward/record.url?scp=33749444606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749444606&partnerID=8YFLogxK

U2 - 10.1097/01.cnd.0000205575.26451.e4

DO - 10.1097/01.cnd.0000205575.26451.e4

M3 - Review article

AN - SCOPUS:33749444606

SN - 1522-0443

VL - 7

SP - 141

EP - 157

JO - Journal of clinical neuromuscular disease

JF - Journal of clinical neuromuscular disease

IS - 3

ER -

Diagnosis and treatment of chronic immune-mediated neuropathies

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this